Abstract
Advanced heart failure is a serious medical condition with a poor prognosis despite optimal medical management. Heart transplantation remains the gold standard for the treatment of advanced heart failure, but it is severely limited by chronic donor shortage. In such scenario, contemporary continuous flow LVAD is emerging as an alternative to transplant in very selected patients. A thorough evaluation of the right ventricular function is mandatory before implantation because the device will support only the left ventricle. Survival is 80 and 70% at 1 and 2 years after LVAD implantation, respectively. During support, patients experience a significant improvement in functional status and quality of life, even if it is still inferior when compared to heart transplantation. LVAD also allows the treatment of severe reversible pulmonary hypertension, decreasing the risk of the transplantation. Most frequent complications observed during support are bleeding and infection. LVAD thrombosis, albeit much less frequent, is a life-threatening event that can lead to pump stop and even death. Treatment options for thrombosis are thrombolytic therapy, LVAD replacement, and urgent transplantation.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Bjork JB, Alton KK, Georgiopoulou VV, Butler J, Kalogeropoulos AP. Defining advanced heart failure: a systematic review of criteria used in clinical trials. J Card Fail. 2016;22(7):569–77.
Lund LH, Edwards LB, Dipchand AI, Goldfarb S, Kucheryavaya AY, Levvey BJ, et al.; International Society for Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: thirty-third adult heart transplantation Report-2016; focus theme: primary diagnostic indications for transplant. J Heart Lung Transplant. 2016;35(10):1158–69.
Eurotransplant International Foundation. Annual Report 2015. https://www.eurotransplant.org/cms/mediaobject.php?file=AR_ET_20153.pdf.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al.; Authors/Task Force Members. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–200.
Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, et al. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant. 2015;34(12):1495–504.
Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al. Third INTERMACS annual report: the evolution of destination therapy in the United States. J Heart Lung Transplant. 2011;30(2):115–23.
Gustafsson F, Rogers JG. Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes. Eur J Heart Fail. 2017;19(5):595–602.
Peura JL, Colvin-Adams M, Francis GS, Grady KL, Hoffman TM, Jessup M, et al.; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association. Circulation. 2012;126(22):2648–67.
Hayek S, Sims DB, Markham DW, Butler J, Kalogeropoulos AP. Assessment of right ventricular function in left ventricular assist device candidates. Circ Cardiovasc Imaging. 2014;7(2):379–89.
Cannata A, Petrella D, Russo CF, Bruschi G, Fratto P, Gambacorta M, et al. Postsurgical intrapericardial adhesions: mechanisms of formation and prevention. Ann Thorac Surg. 2013;95(5):1818–26.
Cannata A, Petrella D, Gambacorta M, Russo CF, Bruschi G, Martinelli L. Histological findings following use of CoSeal in a patient with a left ventricular assist device. Surg Innov. 2013;20(6):NP35–7.
Vitali E, Russo C, Tiziano C, Lanfranconi M, Bruschi G. Modified pericardial closure technique in patients with ventricular assist device. Ann Thorac Surg. 2000;69(4):1278–9.
Starling RC, Estep JD, Horstmanshof DA, Milano CA, Stehlik J, Shah KB, et al.; ROADMAP Study Investigators. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: the ROADMAP Study 2-Year Results. JACC Heart Fail. 2017. pii:S2213-1779(17)30164-6.
Emin A, Rogers CA, Banner NR, Steering Group, UK Cardiothoracic Transplant Audit. Quality of life of advanced chronic heart failure: medical care, mechanical circulatory support and transplantation. Eur J Cardiothorac Surg. 2016;50(2):269–73.
Jakovljevic DG, McDiarmid A, Hallsworth K, Seferovic PM, Ninkovic VM, Parry G, et al. Effect of left ventricular assist device implantation and heart transplantation on habitual physical activity and quality of life. Am J Cardiol. 2014;114(1):88–93.
Arnold SV, Jones PG, Allen LA, Cohen DJ, Fendler TJ, Holtz JE, et al. Frequency of poor outcome (death or poor quality of life) after left ventricular assist device for destination therapy: results from the INTERMACS Registry. Circ Heart Fail. 2016;9(8). pii: e002800.
Grady KL, Wissman S, Naftel DC, Myers S, Gelijins A, Moskowitz A, et al. Age and gender differences and factors related to change in health-related quality of life from before to 6 months after left ventricular assist device implantation: Findings from Interagency Registry for Mechanically Assisted Circulatory Support. J Heart Lung Transplant. 2016;35(6):777–88.
Gupta S, Woldendorp K, Muthiah K, Robson D, Prichard R, Macdonald PS, et al. Normalisation of haemodynamics in patients with end-stage heart failure with continuous-flow left ventricular assist device therapy. Heart Lung Circ. 2014;23(10):963–9.
Mikus E, Stepanenko A, Krabatsch T, Loforte A, Dandel M, Lehmkuhl HB, Hetzer R, Potapov EV. Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients. Eur J Cardiothorac Surg. 2011;40(4):971–7.
Healy AH, Baird BC, Drakos SG, Stehlik J, Selzman CH. Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database. Ann Thorac Surg. 2013;95(3):870–5.
Pereda D, Conte JV. Left ventricular assist device driveline infections. Cardiol Clin. 2011;29:515–27.
Goldstein DJ, Naftel D, Holman W, Bellumkonda L, Pamboukian SV, Pagani FD, et al. Continuous-flow devices and percutaneous site infections: clinical outcomes. J Heart Lung Transplant. 2012;31(11):1151–7.
Kirklin JK, Naftel DC, Kormos RL, Pagani FD, Myers SL, Stevenson LW, et al. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2014;33(1):12–22.
Pae WE, Connell JM, Adelowo A, Boehmer JP, Korfer R, El-Banayosy A, et al.; Clinical Utility Baseline Study (CUBS) Group. Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe. J Heart Lung Transplant. 2007;26(3):219–29.
Bocan KN, Sejdić E. Adaptive transcutaneous power transfer to implantable devices: a state of the art review. Sensors (Basel). 2016;16(3). pii:E393.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Cannata, A., Russo, C.F. (2019). Mechanical Circulatory Support: LVAD in Heart Failure. In: Aseni, P., De Carlis, L., Mazzola, A., Grande, A.M. (eds) Operative Techniques and Recent Advances in Acute Care and Emergency Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-95114-0_52
Download citation
DOI: https://doi.org/10.1007/978-3-319-95114-0_52
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-95113-3
Online ISBN: 978-3-319-95114-0
eBook Packages: MedicineMedicine (R0)